Eckert & Ziegler signs agreement to sell its cyclotron division to Alliance Medical
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Mergers & Acquisitions/Disposal Insider information pursuant to Article 17 MAR Berlin, 5 May, 2017 - Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG (ISIN DE 0005659700), signed an agreement today on the sale of its entire cyclotron division to Alliance Medical Ltd. Eckert & Ziegler will receive a payment in cash in the amount of EUR 13,0 million in return. The corporate division being sold generated sales of around EUR 18 million in 2016, accounting for approximately 13 % of consolidated sales and only a small profit contribution. The sale will be effective as of today. For further information or questions, please contact: Information and Explanation of the Issuer to this News: Additional text: Howard Marsh, Head of Alliance Medicals Radiopharmacy division said: 'The acquisition of Eckert & Zieglers cylclotron division further extends our Molecular Imaging presence in Northern Europe, supplementing both our PET/CT scanning services across the region as well as our radiopharmacy facilities in the UK and Italy. By creating the largest European integrated Radiotracer supply and Imaging organization, we are able to offer a range of solutions to meet all customers needs.' About Eckert & Ziegler
05-May-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | 49 30 941084-138 |
Fax: | 49 30 941084-112 |
E-mail: | karolin.riehle@ezag.de |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Listed: | Regulated Market in Frankfurt (Prime Standard), Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Tradegate Exchange |
End of Announcement | DGAP News Service |